The Magazine for Sleep Professionals
Wednesday, October 7, 2026
The ASA has launched a brand new service to the CPAP industry – the CPAP Provider Competency Program. It offers CPAP providers an independent industry-wide education program for CPAP professionals who initiate and maintain patients on CPAP therapy. “This program is a way for CPAP providers to demonstrate their commitment […]
Takeda announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat […]
Takeda announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. […]
Takeda China announced that the National Medical Products Administration of China has approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1) in adolescents aged 16 years and older and adults. Oveporexton is the first oral orexin receptor 2 (OX2R)-selective agonist approved in China and is the […]
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision […]
The global field of sleep medicine is at a critical inflection point, and at the heart of it lies a shared challenge—the shortage of qualified sleep technologists. With rising awareness of sleep disorders and their link to chronic health conditions, the demand for structured training and certification has surged, particularly […]
Over the years, the BRPT has played a pivotal role in shaping the field of sleep technology, setting high standards for professional competency and ensuring that patients receive quality sleep care that highlights the program’s evolution. One of the key ways in which the BRPT has done that is in […]
Inspire Medical Systems, Inc. announced today the publication of the reimbursement of Inspire therapy in France. “We are thrilled to offer our clinically proven treatment option for moderate to severe OSA to patients and physicians in France,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire. “Inspire therapy is […]
Viatom has announced EU MDR certification (Certificate No. HZ 2120274-1) for its health monitoring devices. This accomplishment signifies a milestone in the company’s unwavering commitment to pursuing excellence and innovation in the medical device industry. The MDR certification obtained by Viatom facilitates access to the European market, opening new horizons […]
First-of-its-kind innovation facility to provide free sleep and respiratory care training for the region’s healthcare professionals Royal Philips announced the opening of Southeast Asia’s first Sleep and Respiratory Education Center at its regional headquarters, the Philips APAC Center in Singapore. A recent study revealed that one in three Singaporeans suffers […]
